Engineering for Cancer Therapies
-
Photo courtesy of Johns Hopkins Medicine Sickle cell disease is caused by an inherited genetic mutation. Current gene therapies are complex, time-consuming, and risky, with some clinical trials revealing serious… Read More
-
Johns Hopkins Medicine scientists say they have developed an artificial lymph node with the potential to treat cancer, according to a new study in mice and human cells. The newly… Read More
-
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found… Read More
-
Joshua Doloff, an assistant professor in the Department of Biomedical Engineering and affiliate researcher at the Institute for NanoBioTechnology, has won a three-year, $450,000 grant from Ovarian Cancer Research Alliance to design new drug delivery systems for more precise treatment of… Read More
-
Researchers from Johns Hopkins University and Universidad Carlos III de Madrid have created a computational model that simulates the growth of breast tumors from a biomechanical perspective. Their innovative approach,… Read More
-
Our immune system is like the police force of our body, generally protecting us from harm such as infection or cancer, explains Johns Hopkins rheumatologist Maximilian F. Konig. When we encounter… Read More
